GP1BA and Thrombocytopenia: Control experiments showed that the Fab fragment of YQ3 antibody did not induce platelet activation or clearance, or any off-target effects when it was injected into the GPIbα/IL4R transgenic mice, indicating that this blocking strategy can avoid thrombocytopenia or bleeding complications in cancer mouse models (129).